Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Chemotherapy in Esthesioneuroblastoma/Olfactory Neuroblastoma: An Analysis of the Surveillance Epidemiology and End Results (SEER) 1973-2015 Database.

Cranmer LD, Chau B, Rockhill JK, Ferreira M Jr, Liao JJ.

Am J Clin Oncol. 2019 Dec 6. doi: 10.1097/COC.0000000000000649. [Epub ahead of print]

PMID:
31842117
2.

Patterns of Failure After Stereotactic Radiosurgery for Recurrent High-Grade Glioma: A Single Institution Experience of 10 Years.

Ene CI, Macomber MW, Barber JK, Ferreira MJ, Ellenbogen RG, Holland EC, Rockhill JK, Silbergeld DL, Halasz LM.

Neurosurgery. 2019 Aug 1;85(2):E322-E331. doi: 10.1093/neuros/nyy520.

PMID:
30576476
3.

Onyx embolization prior to stereotactic radiosurgery for brain arteriovenous malformations: a single-center treatment algorithm.

Nerva JD, Barber J, Levitt MR, Rockhill JK, Hallam DK, Ghodke BV, Sekhar LN, Kim LJ.

J Neurointerv Surg. 2018 Mar;10(3):258-267. doi: 10.1136/neurintsurg-2017-013084. Epub 2017 Jul 14.

PMID:
28710086
4.

Clinical Positioning Accuracy for Multisession Stereotactic Radiotherapy With the Gamma Knife Perfexion.

Smith WP, Young LA, Phillips MH, Cheung M, Halasz LM, Rockhill JK.

Technol Cancer Res Treat. 2017 Jan 1:1533034617708884. doi: 10.1177/1533034617708884. [Epub ahead of print]

5.

Reply to comment on: 'Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach'.

Rockne R, Rockhill JK, Mrugala M, Spence AM, Kalet I, Hendrickson K, Lai A, Cloughesy T, Alvord EC, Swanson KR.

Phys Med Biol. 2016 Apr 7;61(7):2968-9. doi: 10.1088/0031-9155/61/7/2968. Epub 2016 Mar 17. No abstract available.

PMID:
26988701
6.

Addendum to 'A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET'.

Rockne RC, Trister AD, Jacobs J, Hawkins-Daarud AJ, Neal ML, Hendrickson K, Mrugala MM, Rockhill JK, Kinahan P, Krohn KA, Swanson KR.

J R Soc Interface. 2015 Nov 6;12(112). pii: 20150927. doi: 10.1098/rsif.2015.0927. No abstract available.

PMID:
26577597
Free PMC Article
7.

Outcomes of Multimodality Therapy in Pediatric Patients With Ruptured and Unruptured Brain Arteriovenous Malformations.

Nerva JD, Kim LJ, Barber J, Rockhill JK, Hallam DK, Ghodke BV, Sekhar LN.

Neurosurgery. 2016 May;78(5):695-707. doi: 10.1227/NEU.0000000000001076.

PMID:
26509647
8.

Improvement in Visual Fields After Treatment of Intracranial Meningioma With Bevacizumab.

Ly KI, Hamilton SR, Rostomily RC, Rockhill JK, Mrugala MM.

J Neuroophthalmol. 2015 Dec;35(4):382-6. doi: 10.1097/WNO.0000000000000253.

PMID:
26049681
9.

Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513.

Brachman DG, Pugh SL, Ashby LS, Thomas TA, Dunbar EM, Narayan S, Robins HI, Bovi JA, Rockhill JK, Won M, Curran WP.

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):961-7. doi: 10.1016/j.ijrobp.2014.12.050.

10.

The use of stereotactic radiosurgery for brain metastases from breast cancer: who benefits most?

Cho E, Rubinstein L, Stevenson P, Gooley T, Philips M, Halasz LM, Gensheimer MF, Linden HM, Rockhill JK, Gadi VK.

Breast Cancer Res Treat. 2015 Feb;149(3):743-9. doi: 10.1007/s10549-014-3242-x. Epub 2015 Feb 1.

11.

Treatment outcomes of unruptured arteriovenous malformations with a subgroup analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-eligible patients.

Nerva JD, Mantovani A, Barber J, Kim LJ, Rockhill JK, Hallam DK, Ghodke BV, Sekhar LN.

Neurosurgery. 2015 May;76(5):563-70; discussion570; quiz 570. doi: 10.1227/NEU.0000000000000663.

PMID:
25635891
12.

A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET.

Rockne RC, Trister AD, Jacobs J, Hawkins-Daarud AJ, Neal ML, Hendrickson K, Mrugala MM, Rockhill JK, Kinahan P, Krohn KA, Swanson KR.

J R Soc Interface. 2015 Feb 6;12(103). pii: 20141174. doi: 10.1098/rsif.2014.1174. Erratum in: J R Soc Interface. 2015 Nov 6;12(112). pii: 20150927. doi: 10.1098/rsif.2015.0927.

13.

Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas.

Baldock AL, Ahn S, Rockne R, Johnston S, Neal M, Corwin D, Clark-Swanson K, Sterin G, Trister AD, Malone H, Ebiana V, Sonabend AM, Mrugala M, Rockhill JK, Silbergeld DL, Lai A, Cloughesy T, McKhann GM 2nd, Bruce JN, Rostomily RC, Canoll P, Swanson KR.

PLoS One. 2014 Oct 28;9(10):e99057. doi: 10.1371/journal.pone.0099057. eCollection 2014.

14.

Hemorrhagic collision metastasis in a cerebral arteriovenous malformation.

Sundarakumar DK, Marshall DA, Keene CD, Rockhill JK, Margolin KA, Kim LJ.

J Neurointerv Surg. 2015 Oct;7(10):e34. doi: 10.1136/neurintsurg-2014-011362.rep. Epub 2014 Sep 25.

PMID:
25261441
15.

Hemorrhagic collision metastasis in a cerebral arteriovenous malformation.

Sundarakumar DK, Marshall DA, Keene CD, Rockhill JK, Margolin KA, Kim LJ.

BMJ Case Rep. 2014 Sep 19;2014. pii: bcr2014011362. doi: 10.1136/bcr-2014-011362.

16.

Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients.

Adair JE, Johnston SK, Mrugala MM, Beard BC, Guyman LA, Baldock AL, Bridge CA, Hawkins-Daarud A, Gori JL, Born DE, Gonzalez-Cuyar LF, Silbergeld DL, Rockne RC, Storer BE, Rockhill JK, Swanson KR, Kiem HP.

J Clin Invest. 2014 Sep;124(9):4082-92. doi: 10.1172/JCI76739. Epub 2014 Aug 8.

17.

Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status.

Baldock AL, Yagle K, Born DE, Ahn S, Trister AD, Neal M, Johnston SK, Bridge CA, Basanta D, Scott J, Malone H, Sonabend AM, Canoll P, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR.

Neuro Oncol. 2014 Jun;16(6):779-86. doi: 10.1093/neuonc/nou027.

18.

Toward patient-specific, biologically optimized radiation therapy plans for the treatment of glioblastoma.

Corwin D, Holdsworth C, Rockne RC, Trister AD, Mrugala MM, Rockhill JK, Stewart RD, Phillips M, Swanson KR.

PLoS One. 2013 Nov 12;8(11):e79115. doi: 10.1371/journal.pone.0079115. eCollection 2013.

19.

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases.

Halasz LM, Rockhill JK.

Surg Neurol Int. 2013 May 2;4(Suppl 4):S185-91. doi: 10.4103/2152-7806.111295. Print 2013.

20.

From patient-specific mathematical neuro-oncology to precision medicine.

Baldock AL, Rockne RC, Boone AD, Neal ML, Hawkins-Daarud A, Corwin DM, Bridge CA, Guyman LA, Trister AD, Mrugala MM, Rockhill JK, Swanson KR.

Front Oncol. 2013 Apr 2;3:62. doi: 10.3389/fonc.2013.00062. eCollection 2013.

21.

Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression.

Neal ML, Trister AD, Ahn S, Baldock A, Bridge CA, Guyman L, Lange J, Sodt R, Cloke T, Lai A, Cloughesy TF, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR.

Cancer Res. 2013 May 15;73(10):2976-86. doi: 10.1158/0008-5472.CAN-12-3588. Epub 2013 Feb 11.

22.

Discriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metric.

Neal ML, Trister AD, Cloke T, Sodt R, Ahn S, Baldock AL, Bridge CA, Lai A, Cloughesy TF, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR.

PLoS One. 2013;8(1):e51951. doi: 10.1371/journal.pone.0051951. Epub 2013 Jan 23.

23.

Increased age of transformed mouse neural progenitor/stem cells recapitulates age-dependent clinical features of human glioma malignancy.

Mikheev AM, Ramakrishna R, Stoll EA, Mikheeva SA, Beyer RP, Plotnik DA, Schwartz JL, Rockhill JK, Silber JR, Born DE, Kosai Y, Horner PJ, Rostomily RC.

Aging Cell. 2012 Dec;11(6):1027-35. doi: 10.1111/acel.12004. Epub 2012 Oct 11.

24.

Radiation associated tumors following therapeutic cranial radiation.

Chowdhary A, Spence AM, Sales L, Rostomily RC, Rockhill JK, Silbergeld DL.

Surg Neurol Int. 2012;3:48. doi: 10.4103/2152-7806.96068. Epub 2012 May 14.

25.

Extended survival of glioblastoma patients after chemoprotective HSC gene therapy.

Adair JE, Beard BC, Trobridge GD, Neff T, Rockhill JK, Silbergeld DL, Mrugala MM, Kiem HP.

Sci Transl Med. 2012 May 9;4(133):133ra57. doi: 10.1126/scitranslmed.3003425.

26.

Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.

Fink JR, Carr RB, Matsusue E, Iyer RS, Rockhill JK, Haynor DR, Maravilla KR.

J Magn Reson Imaging. 2012 Jan;35(1):56-63. doi: 10.1002/jmri.22801. Epub 2011 Oct 14.

PMID:
22002882
27.

Cancer pain emergencies: is there a role for radiation therapy?

Sales L, Rockhill JK.

Curr Pain Headache Rep. 2010 Dec;14(6):483-8. doi: 10.1007/s11916-010-0136-4. Review.

PMID:
20703832
28.

Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow.

Keene CD, Chang RC, Lopez-Yglesias AH, Shalloway BR, Sokal I, Li X, Reed PJ, Keene LM, Montine KS, Breyer RM, Rockhill JK, Montine TJ.

Am J Pathol. 2010 Jul;177(1):346-54. doi: 10.2353/ajpath.2010.090840. Epub 2010 Jun 3.

29.

Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach.

Rockne R, Rockhill JK, Mrugala M, Spence AM, Kalet I, Hendrickson K, Lai A, Cloughesy T, Alvord EC Jr, Swanson KR.

Phys Med Biol. 2010 Jun 21;55(12):3271-85. doi: 10.1088/0031-9155/55/12/001. Epub 2010 May 18.

30.

Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model.

Wang CH, Rockhill JK, Mrugala M, Peacock DL, Lai A, Jusenius K, Wardlaw JM, Cloughesy T, Spence AM, Rockne R, Alvord EC Jr, Swanson KR.

Cancer Res. 2009 Dec 1;69(23):9133-40. doi: 10.1158/0008-5472.CAN-08-3863. Epub 2009 Nov 24.

31.

Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.

Matsusue E, Fink JR, Rockhill JK, Ogawa T, Maravilla KR.

Neuroradiology. 2010 Apr;52(4):297-306. doi: 10.1007/s00234-009-0613-9. Epub 2009 Oct 16.

PMID:
19834699
32.

A mathematical model for brain tumor response to radiation therapy.

Rockne R, Alvord EC Jr, Rockhill JK, Swanson KR.

J Math Biol. 2009 Apr;58(4-5):561-78. doi: 10.1007/s00285-008-0219-6. Epub 2008 Sep 25.

33.

Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival.

Spence AM, Muzi M, Swanson KR, O'Sullivan F, Rockhill JK, Rajendran JG, Adamsen TC, Link JM, Swanson PE, Yagle KJ, Rostomily RC, Silbergeld DL, Krohn KA.

Clin Cancer Res. 2008 May 1;14(9):2623-30. doi: 10.1158/1078-0432.CCR-07-4995.

34.

A role for endogenous and radiation-induced DNA double-strand breaks in p53-dependent apoptosis during cortical neurogenesis.

Li H, Liu N, Rajendran GK, Gernon TJ, Rockhill JK, Schwartz JL, Gu Y.

Radiat Res. 2008 May;169(5):513-22. doi: 10.1667/RR1230.1.

PMID:
18439043
35.

Advances in radiation therapy for oncologic pain.

Rockhill JK.

Curr Pain Headache Rep. 2007 Aug;11(4):270-5. Review.

PMID:
17686390
36.

Cisplatin-based chemotherapy followed by focal, reduced-dose irradiation for pediatric primary central nervous system germinomas.

Douglas JG, Rockhill JK, Olson JM, Ellenbogen RG, Geyer JR.

J Pediatr Hematol Oncol. 2006 Jan;28(1):36-9.

PMID:
16394891

Supplemental Content

Loading ...
Support Center